Medpace is a leading global full-service clinical research organization providing Phase I-IV core development services for drug, biologic, and device programs. With medical and regulatory expertise in multiple therapeutic specialties, Medpace has assembled the industry’s most experienced and therapeutically focused teams to execute at every level of the company’s operations, providing complete and seamless drug development services. Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development – from program planning and executing to product approval. With clinical trial experience in over 40 countries, Medpace has the global reach and capability to conduct studies and assist with regulatory requirements worldwide.
The Medpace approach creates a therapeutically focused project team, increasing the quality of every service, including the following:
- Medical Expertise
- Regulatory Affairs
- Clinical Operations
- Data Management
- Quality Assurance
- Medical Writing
- Cardiac Safety
- Interactive Voice Response System
Africa, Asia/Pacific, Australia, China, Eastern Europe, India, Latin America, the Middle East, North America, and Western Europe
Medpace Clinical Pharmacology Unit
The Medpace Clinical Pharmacology Unit (Medpace CPU) is a state-of-the-art Phase I, IIa
facility with a core ECG lab focusing on confined/controlled pharmacokinetic/pharmacodynamic
studies utilizing human volunteers, with first-in-man capability.
Medpace Reference Laboratories
Medpace Reference Laboratories (MRL) is a central laboratory with locations in Leuven,
Belgium; Beijing China; Mumbai, India; and Cincinnati, USA. The expertise within Medpace
Reference Laboratories includes coagulation, cardiovascular diseases, oncology, lipids,
diabetes, and other metabolic diseases.
Medpace Reference Laboratories offers clients analytical support during all stages of the
drug development process, with more than 65,000 square feet dedicated to laboratory operations
and specimen storage. Preparation, packaging, and delivery of all supplies and materials
necessary for specimen collection are also managed within the laboratory facilities.
Medpace Bioanalytical Laboratories
The Medpace Bioanalytical Laboratories (MBL) provides bioanalytical services in all stages of
drug development – from discovery to post-marketing. Led by an executive management team that
averages 10-20 years of pharmaceutical and bioanalytical study experience, Medpace is focused
on providing accurate, high-quality results in a timely, secure and cost-effective manner.
Medpace Bioanalytical Laboratories experts work in collaboration with the medical and
regulatory experts at Medpace to partner with your team to transfer and validate difficult
compound assays and ensure fast turnaround of analyses.
Imagepace provides centralized core lab capabilities for managing standard, as well as
innovative imaging modality including magnetic resonance imaging (MRI), computed tomography
(CT), and bone densitometry or dual-energy x-ray absorptiometry (DXA). Standardized
procedures and scientific and operational expertise connect imaging requirements with other
clinical components of the study.
Medpace - Phases IIb, III, IV clinical development, biologicals and device
Medpace Clinical Pharmacology Unit (Medpace CPU) - Phases I, IIa clinical
Medpace Reference Laboratories (MRL) - Centralized laboratory specializing in
cardiovascular and metabolic studies
Imagepace - Imaging core laboratory providing centralized image management,
For more information about Medpace or to receive a project proposal, please contact Catherine Soldano at 513-579-9911 or toll-free at 1-800-730-5779.
For an exciting career move, visit
www.medpace.com and review our
open positions in our career section.
Global Headquarters - USA
5375 Medpace Way
Cincinnati, OH 45227
If you are interested in contacting this company, please complete and submit the form below. A representative from the company will follow up with you.